Align Technology | ALGN - Gross Profit On Sales

Stock Price
178.19
Daily Change
11.32 6.78%
Monthly
1.79%
Yearly
7.97%
Q2 Forecast
165.46

Align Technology reported $683.59M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
3M USD 2.06B 667M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bruker USD 449.2M 69.8M Dec/2025
Cardinal Health USD 2.4B 78M Dec/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Cooper Companies USD 695.2M 44.4M Dec/2025
CVS Health USD 13.57B 239M Dec/2025
Danaher USD 3.97B 443M Dec/2025
Dentsply International USD 443M 2M Dec/2025
Dexcom USD 792.7M 61.3M Dec/2025
Henry Schein USD 1.06B 37M Dec/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Insulet USD 568.6M 58.5M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Masimo USD 247.3M 16.7M Dec/2025
McKesson USD 3.68B 143M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Solventum Corp USD 1.03B 108M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Veeva Systems USD 622.47M 7.11M Dec/2025
Waters USD 557.42M 97.44M Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025
Zoetis USD 1.64B 73M Dec/2025